Print PDF
Axinn Partner Stacie Ropka Named to The Center for Biosimilars’ Board of Advisors
January 7, 2021

Axinn partner Stacie Ropka was named to The Center for Biosimilars’ board of advisors roster as of January 2021.

The Center for Biosimilars is an online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. Those listed on the board of advisors are highly respected authorities in the biosimilars and health care industries, including health economics experts, pharmacists, managed care professionals, and key clinical specialists.

Click here to view the board of advisors roster.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.